Scientists from Aston University in Birmingham, led by Professor Richard Martin, have developed gallium-infused bioactive glass nanoparticles for treating osteosarcoma, …
ETH Zurich researchers have identified vortioxetine, an FDA-approved antidepressant, as a promising candidate in the fight against glioblastoma, a highly …
Arctoris, a contract research organization (CRO) specializing in automated drug discovery, has acquired Eli Lilly's Life Sciences Studio laboratory. The …
Genesis Therapeutics has partnered with Gilead Sciences in a strategic collaboration focusing on Genesis' GEMS (Genesis Exploration of Molecular Space) …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.